Across TCGA pan-cancer cohorts, OR7E148P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR7E148P’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where OR7E148P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E148P is over-expressed in tumor.
BRCA, KICH, and KIRP are the cancer types where OR7E148P tumor–normal differential expression is most reproducible.